1. Home
  2. HOLX vs TEVA Comparison

HOLX vs TEVA Comparison

Compare HOLX & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$75.01

Market Cap

16.6B

Sector

Health Care

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$29.74

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOLX
TEVA
Founded
1985
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Electronics
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.6B
30.2B
IPO Year
1990
N/A

Fundamental Metrics

Financial Performance
Metric
HOLX
TEVA
Price
$75.01
$29.74
Analyst Decision
Hold
Strong Buy
Analyst Count
15
9
Target Price
$79.64
$29.78
AVG Volume (30 Days)
2.9M
10.4M
Earning Date
11-03-2025
01-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.49
0.62
Revenue
$4,100,500,000.00
$16,776,000,000.00
Revenue This Year
$6.69
$4.74
Revenue Next Year
$5.74
$0.48
P/E Ratio
$30.05
$48.90
Revenue Growth
1.74
0.02
52 Week Low
$51.90
$12.47
52 Week High
$76.29
$30.20

Technical Indicators

Market Signals
Indicator
HOLX
TEVA
Relative Strength Index (RSI) 68.00 79.52
Support Level $74.77 $28.00
Resistance Level $75.05 $30.20
Average True Range (ATR) 0.30 0.65
MACD -0.14 0.18
Stochastic Oscillator 86.93 92.58

Price Performance

Historical Comparison
HOLX
TEVA

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: